These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17353638)

  • 21. [Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression].
    Shiiki S; Sonoo H; Seki M; Nomura T; Hironou M; Ookubo S; Udagawa K; Yamamoto Y; Nakashima K; Ikeda M; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1431-5. PubMed ID: 17033232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
    Sakurai K; Enomoto K; Tani M; Kitajima A; Amano S; Shiono M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2222-4. PubMed ID: 19106577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer].
    Tagaya N; Nakagawa A; Mori S; Hamada K; Suzuki N; Kubota K
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):39-42. PubMed ID: 16410696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer].
    Horiguchi J; Koibuchi Y; Rokutanda N; Nagaoka R; Kikuchi M; Sato A; Odawara H; Ishikawa Y; Tokiniwa H; Iino Y; Takeyoshi I
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1877-81. PubMed ID: 19011335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
    O'Shaughnessy JA; Blum JL
    Clin Breast Cancer; 2006 Apr; 7(1):42-50. PubMed ID: 16764743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.
    Michalaki V; Gennatas S; Gennatas K
    Anticancer Drugs; 2009 Mar; 20(3):204-7. PubMed ID: 19174694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.
    Susnjar S; Bosnjak S; Radulovic S; Stevanovic J; Gajic-Dobrosavljevic M; Kreacic M
    J BUON; 2007; 12(2):189-96. PubMed ID: 17600871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.
    Nolè F; Catania C; Munzone E; Rocca A; Verri E; Sanna G; Ascione G; Adamoli L; Zampino MG; Minchella I; Goldhirsch A
    Clin Breast Cancer; 2006 Feb; 6(6):518-24. PubMed ID: 16595035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
    Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
    Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    Blum JL; Dees EC; Chacko A; Doane L; Ethirajan S; Hopkins J; McMahon R; Merten S; Negron A; Neubauer M; Ilegbodu D; Boehm KA; Asmar L; O'Shaughnessy JA
    J Clin Oncol; 2006 Sep; 24(27):4384-90. PubMed ID: 16926223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
    Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results.
    Michalaki V; Fotiou S; Gennatas S; Gennatas C
    Anticancer Res; 2010 Jul; 30(7):3051-4. PubMed ID: 20683054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.
    Hatschek T; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Lindh B; Loman N; Malmberg M; Rotstein S; Söderberg M; Sundquist M; Walz TM; Hellström M; Svensson H; Aström G; Brandberg Y; Carstensen J; Fernö M; Bergh J
    Breast Cancer Res Treat; 2012 Feb; 131(3):939-47. PubMed ID: 22094937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.
    Gick U; Rochlitz C; Mingrone W; Pestalozzi B; Rauch D; Ballabeni P; Lanz D; Hess V; Aebi S
    Oncology; 2006; 71(1-2):54-60. PubMed ID: 17344671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal chemotherapy for advanced and recurrent breast cancer patients].
    Masuda N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():523-9. PubMed ID: 17682205
    [No Abstract]   [Full Text] [Related]  

  • 37. [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
    Umeda T; Abe H; Cho H; Shimizu T; Mori T; Kubota Y; Kawai Y; Tanaka M; Kurumi Y; Tani T
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):687-9. PubMed ID: 20414027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.
    Villanueva C; Awada A; Campone M; Machiels JP; Besse T; Magherini E; Dubin F; Semiond D; Pivot X
    Eur J Cancer; 2011 May; 47(7):1037-45. PubMed ID: 21339064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of breast cancer with brain metastases responding to paclitaxel and capecitabine therapy].
    Sakaguchi K; Mizuta N; Imai A; Nakatsukasa K; Taguchi T
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):261-3. PubMed ID: 22333639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.
    Corey-Lisle PK; Peck R; Mukhopadhyay P; Orsini L; Safikhani S; Bell JA; Hortobagyi G; Roche H; Conte P; Revicki DA
    Cancer; 2012 Jan; 118(2):461-8. PubMed ID: 21598243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.